Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | JAK1 |
Variant | S729C |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | JAK1 S729C lies within the protein kinase domain 1 of the Jak1 protein (UniProt.org). S729C results in constitutive phosphorylation of Jak1 and activation of Stat3, is transforming in culture, and induces gene expression signature consistent with Jak1 activation in patient samples (PMID: 23788652). |
Associated Drug Resistance | |
Category Variants Paths |
JAK1 mutant JAK1 act mut JAK1 S729C |
Transcript | NM_002227.4 |
gDNA | chr1:g.64844820T>A |
cDNA | c.2185A>T |
Protein | p.S729C |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001321855 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001321856 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
XM_047419675.1 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001321853 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
XM_047419674.1 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001321856.2 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001320923.1 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001321852.1 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001321853.2 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_002227.4 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_002227.3 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001321852 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001320923 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001321854.1 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001321855.1 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001320923.2 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001321855.2 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001321854.2 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001321856.1 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_002227 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001321852.2 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001321854 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
NM_001321853.1 | chr1:g.64844820T>A | c.2185A>T | p.S729C | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|